← Back to Clinical Trials
Recruiting NCT05696184

NCT05696184 Mechanisms Preventing Pharyngeal Reflux

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05696184
Status Recruiting
Phase
Sponsor Medical College of Wisconsin
Condition GERD
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2013-11-01
Primary Completion 2026-10-12

Trial Parameters

Condition GERD
Sponsor Medical College of Wisconsin
Study Type INTERVENTIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2013-11-01
Completion 2026-10-12
Interventions
Concurrent manometry/impedance/pH with video pharyngo-laryngoscopySlow and rapid intra-esophageal infusion

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The overall goal is to define and characterize the manometric characteristics of UES incompetence associated with objectively documented pharyngeal reflux. The investigators will use endoscopic reflux detection as gold standard.

Eligibility Criteria

Inclusion Criteria: * Age 18 to 85 * GERD patients with complaints of regurgitation and supra-esophageal symptoms will be included and recruited from our GI \& Otolaryngology clinics * GERD patients without complaint of supra-esophageal symptoms and regurgitation will be included and recruited from our GI \& Otolaryngology clinics * Asthma patients with and without supra-esophageal symptoms will be included and recruited from clinics affiliated with Medical College of Wisconsin. Asthma patients with the following classifications of asthma severity will be included: intermittent, mild persistent, moderate persistent, and severe persistent (as long as no acute asthma exacerbation at the time of the study) * Patient definition will be based on position statement and technical reviews of the American Gastroenterological Association and Montreal definition and classification of gastroesophageal and reflux disease (Am J Gastroenterol. 2006;101:1900-1920). * SERD is defined as patients on lon

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology